相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。In Vitro and In Vivo Synergism of Fosfomycin in Combination with Meropenem or Polymyxin B against KPC-2-Producing Klebsiella pneumoniae Clinical Isolates
Aghata Cardoso da Silva Ribeiro et al.
ANTIBIOTICS-BASEL (2023)
A novel KPC-113 variant conferring carbapenem and ceftazidime- avibactam resistance in a multidrug-resistant Pseudomonas aeruginosa isolate
Qing Yang et al.
CLINICAL MICROBIOLOGY AND INFECTION (2023)
Comparative Evaluation of Phenotypic Synergy Tests versus RESIST-4 OKNV and NG Test Carba 5 Lateral Flow Immunoassays for the Detection and Differentiation of Carbapenemases in Enterobacterales and Pseudomonas aeruginosa
Diego M. Josa et al.
MICROBIOLOGY SPECTRUM (2022)
Identification of a KPC Variant Conferring Resistance to Ceftazidime-Avibactam from ST11 Carbapenem-Resistant Klebsiella pneumoniae Strains
Yuchen Wu et al.
MICROBIOLOGY SPECTRUM (2022)
Outbreak of Klebsiella pneumoniae ST11 Resistant To Ceftazidime-Avibactam Producing KPC-31 and the Novel Variant KPC-115 during COVID-19 Pandemic in Argentina
Federico Nicola et al.
MICROBIOLOGY SPECTRUM (2022)
Virulomic Analysis of Multidrug-Resistant Klebsiella pneumoniae Isolates and Experimental Virulence Model Using Danio rerio (Zebrafish)
Edson Luiz Tarsia Duarte et al.
ANTIBIOTICS-BASEL (2022)
The Gastrointestinal Load of Carbapenem-Resistant Enterobacteriacea Is Associated With the Transition From Colonization to Infection by Klebsiella pneumoniae Isolates Harboring the blaKPC Gene
Leticia Busato Migliorini et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2022)
Prognostic Significance of the Relative Load of KPC-Producing Klebsiella pneumoniae within the Intestinal Microbiota in a Prospective Cohort of Colonized Patients
Elena Perez-Nadales et al.
MICROBIOLOGY SPECTRUM (2022)
Nosocomial Outbreak of Extensively Drug-Resistant (Polymyxin B and Carbapenem) Klebsiella pneumoniae in a Collapsed University Hospital Due to COVID-19 Pandemic
Gilberto G. Gaspar et al.
ANTIBIOTICS-BASEL (2022)
Klebsiella pneumoniae Carbapenemase Variants Resistant to Ceftazidime-Avibactam: an Evolutionary Overview
Claire Amaris Hobson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)
Risk factors for carbapenem-resistant Enterobacterales infection among hospitalized patients with previous colonization
Xia Chen et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2022)
Detecting KPC-2 and NDM-1 Coexpression in Klebsiella pneumoniae Complex from Human and Animal Hosts in South America
Felipe Vasquez-Ponce et al.
MICROBIOLOGY SPECTRUM (2022)
Update on the epidemiology of carbapenemases in Latin America and the Caribbean
Juan Carlos Garcia-Betancur et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2021)
Characterization of an emergent high-risk KPC-producing Klebsiella pneumoniae lineage causing a fatal wound infection after spine surgery
Luana Boff et al.
INFECTION GENETICS AND EVOLUTION (2021)
Vertical and horizontal dissemination of an IncC plasmid harbouring rmtB 16S rRNA methylase gene, conferring resistance to plazomicin, among invasive ST258 and ST16 KPC-producing Klebsiella pneumoniae
Melanie Roch et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2021)
Comparison of Four Carbapenemase Detection Methods for blaKPC-2 Variants
Li Ding et al.
MICROBIOLOGY SPECTRUM (2021)
Emergence of a KPC Variant Conferring Resistance to Ceftazidime-Avibactam in a Widespread ST11 Carbapenem-Resistant Klebsiella pneumoniae Clone in China
Xi Li et al.
FRONTIERS IN MICROBIOLOGY (2021)
An Emerging Clone, Klebsiella pneumoniae Carbapenemase 2-Producing K. pneumoniae Sequence Type 16, Associated With High Mortality Rates in a CC258-Endemic Setting
Diego O. Andrey et al.
CLINICAL INFECTIOUS DISEASES (2020)
KPC-50 Confers Resistance to Ceftazidime-Avibactam Associated with Reduced Carbapenemase Activity
Laurent Poirel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Carbapenemase-ProducingKlebsiella pneumoniaeFrom Transplanted Patients in Brazil: Phylogeny, Resistome, Virulome and Mobile Genetic Elements HarboringblaKPC-2orblaNDM-1
Otavio Hallal Ferreira Raro et al.
FRONTIERS IN MICROBIOLOGY (2020)
Changing epidemiology of KPC-producing Klebsiella pneumoniae in Argentina: Emergence of hypermucoviscous ST25 and high-risk clone ST307
Daniela Cejas et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2019)
Risks of Infection and Mortality Among Patients Colonized With Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Validation of Scores and Proposal for Management
Angela Cano et al.
CLINICAL INFECTIOUS DISEASES (2018)
The epidemiology of carbapenemases in Latin America and the Caribbean
Kevin Escandon-Vargas et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2017)
Resistance to Ceftazidime-Avibactam in Klebsiella pneumoniae Due to Porin Mutations and the Increased Expression of KPC-3
Romney M. Humphries et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Multiclonal Expansion of Klebsiella pneumoniae Isolates Producing NDM-1 in Rio de Janeiro, Brazil
Caio Augusto Martins Aires et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Global Dissemination of Carbapenemase-Producing Klebsiella pneumoniae: Epidemiology, Genetic Context, Treatment Options, and Detection Methods
Chang-Ro Lee et al.
FRONTIERS IN MICROBIOLOGY (2016)
First Report of Ceftazidime-Avibactam Resistance in a KPC-3-Expressing Klebsiella pneumoniae Isolate
Romney M. Humphries et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study
M. Giannella et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)